Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing v3.0.1. The Back to Top link has been removed.
    Difference
    0.7%
    Check dated 2025-09-14T19:25:39.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-07T16:17:54.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    22%
    Check dated 2025-08-31T12:04:03.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:23:53.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-10T00:22:41.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T18:48:24.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.